Monday, October 12, 2026

Fiscal Policy & Government Finance

2 articles

Social Security Insolvency Accelerates to 2032 as Tax Cuts Slash $1.1 Trillion in Revenue

Social Security Insolvency Accelerates to 2032 as Tax Cuts Slash $1.1 Trillion in Revenue

The One Big Beautiful Bill Act pushes Social Security fund depletion to 2032-2035 through tax cuts that reduce federal revenue by $1.1 trillion. Congressional Budget Office projections show automatic benefit cuts will hit when funds deplete, while only 24% of current beneficiaries gain tax relief. The collision arrives as Fed Chair Jerome Powell's term expires May 2026, creating monetary-fiscal policy uncertainty for investors.

ViaNews Editorial Team (Finance)•
OBBBA Tax Cuts Could Push Social Security Insolvency to 2032, Threaten Bank Depositor Base

OBBBA Tax Cuts Could Push Social Security Insolvency to 2032, Threaten Bank Depositor Base

The One Big Beautiful Bill Act combines $1.1 trillion in federal spending cuts with tax relief that independent analysts warn could accelerate Social Security insolvency from 2035 to 2032. The Congressional Budget Office projects 11.8 million Americans will lose health insurance by 2034 due to Medicaid cuts, while 33% benefit reductions loom for Social Security recipients. Banks and insurers face a shrinking middle-class customer base as fiscal pressures mount.

ViaNews Editorial Team (Finance)•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,371 source documents archived
Query this data → isubstrate.com